W. William Schluter, MD - Director, Global Immunization Division
Dr. Schluter is the Director of the Global Immunization Division in the Center for Global Health at the U.S. Centers for Disease Control and Prevention (CDC). He has worked towards the eradication, elimination, and control of vaccine-preventable diseases for more than 20 years in a variety of settings.
Most recently, Dr. Schluter was on detail from CDC to the World Health Organization (WHO) Western Pacific Regional Office, from 2012 to 2017, serving as the Group Lead for Accelerated Disease Control for the Expanded Program on Immunization Unit providing support to the 37 countries and areas of the Western Pacific. Prior to that position, he was detailed to the WHO Nepal Country Office, from 2009 to 2012, as the Team Lead for the Immunization Preventable Diseases Unit and to the WHO Ethiopia Country Office, from 2004-2007, coordinating programmatic and surveillance activities for vaccine-preventable diseases.
Dr. Schluter graduated from the Creighton University School of Medicine in 1990 and received a Master of Science in Public Health from the University of Colorado in 1995. He completed residency training in both Family Medicine at the University of Wyoming and General Preventive Medicine and Public Health at the University of Colorado. Dr. Schluter started his career at CDC as an Epidemic Intelligence Service Officer, 1995-1997, in the National Immunization Program in the Measles, Mumps, Rubella, and Varicella Activity.
Recent Publications — Dr. William Schluter
- Experience with Inactivated Polio Vaccine Introduction and the “Switch” from Trivalent to Bivalent Oral Polio Vaccine in the World Health Organization’s Western Pacific Region. The Journal of Infectious Diseases, JID 2017:216 (Suppl 1); S101-8.
- Impact of an Intervention to Use a Measles, Rubella, and Polio Mass Vaccination Campaign to Strengthen Routine Immunization Services in Nepal. The Journal of Infectious Diseases, JID 2017:216 (Suppl 1); S280-6.
- National, Regional and Global Certification Bodies for Polio Eradication: A Framework for Verifying Measles Elimination. The Journal of Infectious Diseases, . JID 2017:216 (Suppl 1); S351-4.
- The effect of diarrheal disease on bivalent oral polio vaccine (bOPV) immune response in infants in Nepal. Vaccine April 2016 11;34(22):2519-26.
- World Health Organization Experts’ Clarification of Key Technical Issues on Implementation of the Polio Endgame Strategic Plan in China. Chinese Journal of Vaccines and Immunization 2015;12(4).
- Development of a district-level programmatic assessment tool for risk of measles virus transmission. Risk Analysis 2015 May 15.
- Using the World Health Organization measles programmatic risk assessment tool for monitoring of supplemental immunization activities in the Philippines. Risk Analysis 2015 May 7.
- Progress toward measles elimination—Philippines, 1998-2014. MMWR Morbidity and Mortality Weekly Report. 2015 Apr 10;64(13):357-62.
- Page last reviewed: September 18, 2017
- Page last updated: September 18, 2017
- Content source:
Notice: Linking to a non-federal site does not constitute an endorsement by HHS, CDC or any of its employees of the sponsors or the information and products presented on the site.